Identification of twelve non-toxic oligopeptides with cytostatic effects on three breast cancer cell lines.

Abstract


We report a significant detection of bioactive content with anti-tumor effects in the blood after exerting a particular therapeutic stimulus on a voluntary patient. Concentration estimations show an increase of 0.48mg/mL as a results of the therapeutic stimulus.  This increase was then analyzed and sequenced using proteomics and revealed a cocktail of peptides which kill specific breast cancer cell types in vitro.

 

 

 

   

Recent developments

What is Sanare's activity? Are you in a hurry or looking for a brief explanation of Sanare's activity? Read more...

November 2009: Full studies from Charles River Laboratories, Ann Arbor.
October 2009: International patent survey successful. PCT patenting process to start in 2010. Read more...
 
 
Ongoing Research
- "Identification of twelve non-toxic oligopeptides with cytostatic effects on three breast cancer cell lines."  Read More...

 

 

Copyright © 2007-2008 Sanare A.S.
Sanare A.S. Tinghaugveien 435, 3175 Ramnes. Norway.  Org. nr. 991489029 
Tel: +47 9132 7347 Fax: +47 3339 7855